Below are some of the key findings from the biologics manufacturing market research report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Get a FREE sample now!
Global Biologics Manufacturing Industry Overview
A key factor driving the growth of the market is the introduction of new biologic drugs for treating diseases. The demand for biologics for the more effective treatment of diseases is growing as synthetic drugs have several limitations. Therefore, the development of new biologics for the treatment of existing disorders and rare conditions is expected to fuel the growth of the biologics manufacturing industry. The rise in partnership between biopharma companies and biotechnology startups is one of the key emerging trends in the global biologic development process market. These factors are expected to impact the market outlook, thus registering a CAGR of more than 9% in the forecast period
Top biologics manufacturing companies covered in this market research report
The biologics manufacturing market is moderately fragmented. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this biologic manufacturing industry analysis report will aid clients to identify new growth opportunities and design new growth strategies.
The report offers a complete analysis of various companies including:
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck & Co
- Pfizer
Biologics manufacturing market segmentation based on geographic regions
With a complete study of the growth opportunities for the companies, the APAC region will account for the highest growth of this market throughout the forecast period.
Biologics manufacturing market segmentation based on products
The biologics will account for the highest market share while biosimilars will have highest market growth. Additionally, the report also provides an accurate prediction of the contribution of the various products segments to the growth of the biologics manufacturing market size.
Key highlights of the global biologics manufacturing market for the forecast years 2018-2022:
- CAGR of the market during the forecast period 2018-2022
- Detailed information on factors that will accelerate the growth of the biologics manufacturing market during the next five years
- Precise estimation of the global biologics manufacturing market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the biologics manufacturing industry across the Americas, APAC, and EMEA
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details on the factors that will challenge the growth of biologics manufacturing companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY TECHNOLOGY
- Segmentation by technology
- Comparison by technology
- In-house – Market size and forecast 2017-2022
- Outsourced – Market size and forecast 2017-2022
- Market opportunity by technology
PART 08: MARKET SEGMENTATION BY PRODUCT
- Segmentation by product
- Comparison by product
- Biologics – Market size and forecast 2017-2022
- Biosimilars – Market size and forecast 2017-2022
- Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas – Market size and forecast 2017-2022
- EMEA – Market size and forecast 2017-2022
- APAC – Market size and forecast 2017-2022
- Key leading countries
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: MARKET TRENDS
- Rise in partnerships between traditional biopharma companies and biotechnology startups
- Growing outsourcing of biologics manufacturing
- Increase in FDA approvals for new biologics products
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck & Co.
- Pfizer
PART 16: APPENDIX
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape